Natural Response
- Manufacturer
- Newton Laboratories, Inc.
- Effective date
- 2014-11-10
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-06-01 02:06:13
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
INDICATIONS & USAGE SECTION
Formulated for symptoms associated with injuries, bites and infections such as restlessness, bleeding, pain, nausea, vomiting, swelling, trembling and confusion.
DOSAGE & ADMINISTRATION SECTION
Directions: Ages 12 and up, take 6 pellets by mouth (ages 0 to 11, give 3 pellets) as needed or as directed by a health professional. Under age 2, crush/dissolve pellets in purified water. Sensitive persons begin with 1 pellet and gradually increase to full dose. Warning: For use as an interim therapy. Seek professional medical intervention for severe injuries, bites or infections.
OTC - ACTIVE INGREDIENT SECTION
Aconitum nap. 10x, Arnica 10x, Arsenicum alb. 10x, Bryonia 10x, Echinacea 10x, Ledum 10x, Cenchris 15x, Crotalus casc. 15x, Crotalus hor. 15x, Lachesis 15x, Merc. corros. 15x, Naja 15x, Phos. 15x, Toxicophis 15x, Vipera 15x, Elaps cor. 30x, Heloderma 30x.
OTC - PURPOSE SECTION
Formulated for symptoms associated with injuries, bites and infections such as restlessness, bleeding, pain, nausea, vomiting, swelling, trembling and confusion.
INACTIVE INGREDIENT SECTION
Inactive Ingredients: Gluten-free, non-GMO, beet-derived sucrose pellets.
QUESTIONS SECTION
www.newtonlabs.net Newton Laboratories, Inc. FDA Est # 1051203 - Conyers, GA 30012
Questions? 1.800.448.7256
WARNINGS SECTION
Warning: Keep out of reach of children. Do not use if tamper-evident seal is broken or missing. If symptoms worsen or persist for more than a few days, consult a doctor. If pregnant or breast-feeding, ask a doctor before use.
OTC - PREGNANCY OR BREAST FEEDING SECTION
If pregnant or breast-feeding, ask a doctor before use.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children.
PACKAGE LABEL
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 63f39a63-5cd1-4016-bd86-2bbb0f6c3139 | Product name | 3 | 20240506 |
| e5a77e9c-c528-733a-173d-914a234c024b | Product name | 5 | 20240506 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 55714-2367-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-3a72-f424-e053-dadaa90a57ce | Natural Response |
| 55714-2367-2 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-3a72-f424-e053-dadaa90a57ce | Natural Response |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 55714-2367-1 | Natural Response | 28 g in 1 BOTTLE, GLASS | PELLET | 28 | 1 | |
| 55714-2367-2 | Natural Response | 57 g in 1 BOTTLE, GLASS | PELLET | 57 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 55714-2367 | NATURAL RESPONSE (ACONITUM NAP., ARNICA, ARSENICUM ALB., BRYONIA, ECHINACEA, LEDUM, CENCHRIS, CROTALUS CASC. CROTALUS HOR., LACHESIS, MERC. CORROS., NAJA, PHOS., TOXICOPHIS, VIPERA, ELAPS COR., HELODERMA) PELLET [NEWTON LABORATORIES, INC.] | 1 | Legacy NDC, 2 package rows | 20141204_83a604ab-950f-40ec-9e44-fbfa36b04a99.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Aconitum Napellus | ACTIVE INGREDIENT | U0NQ8555JD | 1 | |
| Agkistrodon Contortrix Venom | ACTIVE INGREDIENT | 3BKX485ZP0 | 1 | |
| Agkistrodon Piscivorus Venom | ACTIVE INGREDIENT | X9V1Q8U150 | 1 | |
| Arnica Montana | ACTIVE INGREDIENT | O80TY208ZW | 1 | |
| Arsenic Trioxide | ACTIVE INGREDIENT | S7V92P67HO | 1 | |
| Bryonia Alba Root | ACTIVE INGREDIENT | T7J046YI2B | 1 | |
| Crotalus Durissus Terrificus Venom | ACTIVE INGREDIENT | 2XF6I0446G | 1 | |
| Crotalus Horridus Horridus Venom | ACTIVE INGREDIENT | YHA2XLJ956 | 1 | |
| Echinacea, Unspecified | ACTIVE INGREDIENT | 4N9P6CC1DX | 1 | |
| Heloderma Suspectum Venom | ACTIVE INGREDIENT | KV57S96367 | 1 | |
| Lachesis Muta Venom | ACTIVE INGREDIENT | VSW71SS07I | 1 | |
| Ledum Palustre Twig | ACTIVE INGREDIENT | 877L01IZ0P | 1 | |
| Mercuric Chloride | ACTIVE INGREDIENT | 53GH7MZT1R | 1 | |
| Micrurus Corallinus Venom | ACTIVE INGREDIENT | V0S6H36980 | 1 | |
| Naja Naja Venom | ACTIVE INGREDIENT | ZZ4AG7L7VM | 1 | |
| Phosphorus | ACTIVE INGREDIENT | 27YLU75U4W | 1 | |
| Vipera Berus Venom | ACTIVE INGREDIENT | 0ORO6NCA4M | 1 | |
| Aconitum Napellus | ACTIVE MOIETY | U0NQ8555JD | 1 | |
| Agkistrodon Contortrix Venom | ACTIVE MOIETY | 3BKX485ZP0 | 1 | |
| Agkistrodon Piscivorus Venom | ACTIVE MOIETY | X9V1Q8U150 | 1 | |
| Arnica Montana | ACTIVE MOIETY | O80TY208ZW | 1 | |
| Arsenic Cation (3+) | ACTIVE MOIETY | C96613F5AV | 1 | |
| Bryonia Alba Root | ACTIVE MOIETY | T7J046YI2B | 1 | |
| Crotalus Durissus Terrificus Venom | ACTIVE MOIETY | 2XF6I0446G | 1 | |
| Crotalus Horridus Horridus Venom | ACTIVE MOIETY | YHA2XLJ956 | 1 | |
| Echinacea, Unspecified | ACTIVE MOIETY | 4N9P6CC1DX | 1 | |
| Heloderma Suspectum Venom | ACTIVE MOIETY | KV57S96367 | 1 | |
| Lachesis Muta Venom | ACTIVE MOIETY | VSW71SS07I | 1 | |
| Ledum Palustre Twig | ACTIVE MOIETY | 877L01IZ0P | 1 | |
| Mercuric Cation | ACTIVE MOIETY | ED30FJ8Y42 | 1 | |
| Micrurus Corallinus Venom | ACTIVE MOIETY | V0S6H36980 | 1 | |
| Naja Naja Venom | ACTIVE MOIETY | ZZ4AG7L7VM | 1 | |
| Phosphorus | ACTIVE MOIETY | 27YLU75U4W | 1 | |
| Vipera Berus Venom | ACTIVE MOIETY | 0ORO6NCA4M | 1 | |
| Sucrose | INACTIVE INGREDIENT | C151H8M554 | 1 |
Products#
Every source-derived product name is available through these pages.
- Natural Response
- Aconitum nap., Arnica, Arsenicum alb., Bryonia, Echinacea, Ledum, Cenchris, Crotalus casc. Crotalus hor., Lachesis, Merc. corros., Naja, Phos., Toxicophis, Vipera, Elaps cor., Heloderma
- Aconitum Napellus
- Arnica Montana
- Arsenic Trioxide
- Arsenic Cation (3+)
- Bryonia Alba Root
- Echinacea, Unspecified
- Ledum Palustre Twig
- Agkistrodon Contortrix Venom
- Crotalus Durissus Terrificus Venom
- Crotalus Horridus Horridus Venom
- Lachesis Muta Venom
- Mercuric Chloride
- Mercuric Cation
- Naja Naja Venom
- Phosphorus
- Agkistrodon Piscivorus Venom
- Vipera Berus Venom
- Micrurus Corallinus Venom
- Heloderma Suspectum Venom
- Sucrose
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 55714-2367 | 55714-2367-1, 55714-2367-2 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Sucrose | SUCROSE | C151H8M554 | INJECTION, SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | 1 mg | ||
| Sucrose | SUCROSE | C151H8M554 | TROCHE / BUCCAL | NA | ||
| Sucrose | SUCROSE | C151H8M554 | LOZENGE / BUCCAL | NA | ||
| Sucrose | SUCROSE | C151H8M554 | SUSPENSION/ DROPS / ORAL | 3750 mg | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTION / INTRAVENOUS | 1950 mg | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS | 308 mg | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET / ORAL | 4249 mg | ||
| Sucrose | SUCROSE | C151H8M554 | SUSPENSION, EXTENDED RELEASE / ORAL | 5400 mg | ||
| Sucrose | SUCROSE | C151H8M554 | CAPSULE, DELAYED RELEASE / ORAL | 955 mg | ||
| Sucrose | SUCROSE | C151H8M554 | POWDER / ORAL | 27768 mg | ||
| Sucrose | SUCROSE | C151H8M554 | GRANULE, FOR SOLUTION / ORAL | 42596 mg | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTION, SUSPENSION, LIPOSOMAL / INTRAVENOUS | 9.4 %w/v | ||
| Sucrose | SUCROSE | C151H8M554 | SUSPENSION / ORAL | 48209 mg | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET, FILM COATED / ORAL | 145 mg | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS | 900 mg | ||
| Sucrose | SUCROSE | C151H8M554 | SUPPOSITORY / RECTAL | NA | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 2000 mg | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTION, SOLUTION / INTRAVENOUS | NA | ||
| Sucrose | SUCROSE | C151H8M554 | CAPSULE, EXTENDED RELEASE / ORAL | 619 mg | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET, EXTENDED RELEASE / ORAL | 284.54 mg | ||
| Sucrose | SUCROSE | C151H8M554 | POWDER, FOR SOLUTION / ORAL | 38666 mg | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 119.12 mg | ||
| Sucrose | SUCROSE | C151H8M554 | ELIXIR / ORAL | 18000 mg | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET, DELAYED RELEASE / ORAL | 295.33 mg | ||
| Sucrose | SUCROSE | C151H8M554 | GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL | 18790 mg | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTION / SUBCUTANEOUS | 47.75 mg | ||
| Sucrose | SUCROSE | C151H8M554 | CAPSULE, COATED, EXTENDED RELEASE / ORAL | 86 mg | ||
| Sucrose | SUCROSE | C151H8M554 | SOLUTION / ORAL | 70000 mg | ||
| Sucrose | SUCROSE | C151H8M554 | WAFER / ORAL | 155.2 mg | ||
| Sucrose | SUCROSE | C151H8M554 | DROPS / ORAL | NA | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET, CHEWABLE / ORAL | 7258 mg | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET, COATED / ORAL | 516.42 mg | ||
| Sucrose | SUCROSE | C151H8M554 | CAPSULE / ORAL | 3568 mg | ||
| Sucrose | SUCROSE | C151H8M554 | GRANULE, FOR SUSPENSION / ORAL | 31885 mg | ||
| Sucrose | SUCROSE | C151H8M554 | PASTILLE / ORAL | 426 mg | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET / SUBLINGUAL | 109 mg | ||
| Sucrose | SUCROSE | C151H8M554 | POWDER, FOR SUSPENSION / ORAL | 40017 mg | ||
| Sucrose | SUCROSE | C151H8M554 | TROCHE / ORAL | NA | ||
| Sucrose | SUCROSE | C151H8M554 | LOZENGE / TRANSMUCOSAL | 1255 mg | ||
| Sucrose | SUCROSE | C151H8M554 | CAPSULE, COATED PELLETS / ORAL | 59.8 mg | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET / BUCCAL | 109 mg | ||
| Sucrose | SUCROSE | C151H8M554 | GRANULE / ORAL | NA | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTABLE, LIPOSOMAL / INTRAVENOUS | 7560 mg | ||
| Sucrose | SUCROSE | C151H8M554 | LIQUID / ORAL | 37500 mg | ||
| Sucrose | SUCROSE | C151H8M554 | CONCENTRATE / ORAL | 4800 mg | ||
| Sucrose | SUCROSE | C151H8M554 | SOLUTION / RECTAL | 35.42 %w/v | ||
| Sucrose | SUCROSE | C151H8M554 | SYRUP / ORAL | 46400 mg | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTION, EMULSION / INTRAVENOUS | 970 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| bcb97377-de7d-6300-5e43-da545227e306 | 83a604ab-950f-40ec-9e44-fbfa36b04a99 | 2014-11-10 | Warnings | bcb97377-de7d-6300-5e43-da545227e306 83a604ab-950f-40ec-9e44-fbfa36b04a99 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
